Literature DB >> 7421914

Suppression of thyroid radioiodine uptake by various doses of stable iodide.

E Sternthal, L Lipworth, B Stanley, C Abreau, S L Fang, L E Braverman.   

Abstract

We studied the effect of various doses of sodium iodide on thyroid radioiodine uptake in euthyroid volunteers by giving single doses of 10, 30, 50, and 100 mg and then daily doses of 10, 15, 30, 50, or 100 mg for 12 days thereafter. All single doses above 10 mg suppressed 24-hour thyroid uptake of 123I to 0.7 to 1.5 per cent. Continued daily administration of 15 mg of iodide or more resulted in values consistently below 2 per cent. A small but statistically significant fall in serum thyroxine (T4) and triiodothyronine (T3) and a rise in serum thyrotropin (TSH) concentrations were observed after eight and 12 days of iodide treatment. These data suggest that the thyroid uptake of radioactive iodine can be markedly suppressed by single-dose administration of 30 mg of stable iodide and that suppression can be maintained with daily doses of at least 15 mg. This study provides guidelines for stable iodide prophylaxis in the event of exposure to radioactive iodine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7421914     DOI: 10.1056/NEJM198011063031903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).

Authors:  F Soriguer; P Santiago; L Vila; J M Arena; E Delgado; F Díaz Cadórniga; S Donnay; M Fernández Soto; S González-Romero; P Martul; M Puig Domingo; S Ares; F Escobar del Rey; G Morreale de Escobar
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

2.  Guidelines for iodine prophylaxis as a protective measure: information for physicians.

Authors:  Sumito Yoshida; Mayo Ojino; Takayoshi Ozaki; Takushi Hatanaka; Kaori Nomura; Masami Ishii; Kazuaki Koriyama; Makoto Akashi
Journal:  Japan Med Assoc J       Date:  2014-05-01

3.  American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency.

Authors:  Angela M Leung; Andrew J Bauer; Salvatore Benvenga; Alina V Brenner; James V Hennessey; James R Hurley; Stacey A Milan; Arthur B Schneider; Krishnamurthi Sundaram; Daniel J Toft
Journal:  Thyroid       Date:  2017-06-21       Impact factor: 6.568

4.  After Chernobyl--how U.S. physicians respond to radioactive fallout.

Authors:  A E Winder; M A Stanitis; A M Stoddard
Journal:  Public Health Rep       Date:  1988 Mar-Apr       Impact factor: 2.792

5.  Resolution concerning the stockpiling of potassium iodide in New York City in the event of a nuclear accident. The Committee on Public Health, The New York Academy of Medicine.

Authors: 
Journal:  Bull N Y Acad Med       Date:  1981-06

6.  Physiological basis for the use of potassium iodide as a thyroid blocking agent logistic issues in its distribution.

Authors:  D V Becker
Journal:  Bull N Y Acad Med       Date:  1983-12

7.  Prevention of DNA double-strand breaks induced by radioiodide-(131)I in FRTL-5 thyroid cells.

Authors:  Jerome M Hershman; Armen Okunyan; Yelena Rivina; Sophie Cannon; Victor Hogen
Journal:  Endocrinology       Date:  2010-12-29       Impact factor: 4.736

8.  Uncertainty quantification of bioassay functions for the internal dosimetry of radioiodine.

Authors:  Tae-Eun Kwon; Yoonsun Chung; Jaeryong Yoo; Wi-Ho Ha; Minsu Cho
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

Review 9.  Adverse reactions and drug interactions with radiopharmaceuticals.

Authors:  C B Sampson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

10.  Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

Authors:  S M Larson; J A Carrasquillo; K A Krohn; J P Brown; R W McGuffin; J M Ferens; M M Graham; L D Hill; P L Beaumier; K E Hellström
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.